• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

26.36 -0.18 (-0.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 645,462
Open 26.50
Bid (Size) 26.01 (4)
Ask (Size) 26.70 (2)
Prev. Close 26.54
Today's Range 25.95 - 26.50
52wk Range 25.95 - 41.61
Shares Outstanding 57,031,297
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
October 06, 2025
 
Via Benzinga
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents an 'Affordable Growth' Opportunity
September 26, 2025
Harmony Biosciences (HRMY) offers affordable growth with strong EPS & revenue expansion, a low P/E ratio, and robust profitability in rare neurological treatments. 
Via Chartmill

Performance

YTD
-24.3%
-24.3%
1 Month
-18.9%
-18.9%
3 Month
-24.1%
-24.1%
6 Month
-10.7%
-10.7%
1 Year
-25.7%
-25.7%

More News

Read More
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (6 Ratings)
September 25, 2025
Via Benzinga
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday
September 24, 2025
Via Benzinga
Earnings Scheduled For August 5, 2025
August 05, 2025
Via Benzinga
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
September 24, 2025
Via Stocktwits
Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study
September 24, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 24, 2025
Via Benzinga
Harmony Biosciences Whiffs In 'Undruggable' Genetic Disease; Shares Tumble
September 24, 2025
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 24, 2025
Via Benzinga
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
September 24, 2025
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity
September 18, 2025
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Top Affordable Growth Stock
September 04, 2025
Via Chartmill
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
August 26, 2025
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity
August 22, 2025
Via Chartmill
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
August 21, 2025
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY): A Prime Affordable Growth Stock with Strong Fundamentals
August 13, 2025
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY): A Strong Growth Stock with Promising Technical Setup
August 09, 2025
Via Chartmill
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025
August 05, 2025
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity with Strong Fundamentals and Growth Potential
July 26, 2025
Via Chartmill
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY) – A Strong Growth Stock with Attractive Valuation
July 19, 2025
Via Chartmill
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
July 15, 2025
From Harmony Biosciences
Via Business Wire
6 Analysts Assess Harmony Biosciences Hldgs: What You Need To Know
July 10, 2025
Via Benzinga
Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
July 10, 2025
Via Investor's Business Daily
Topics Intellectual Property

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 26.36
When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 10/13/25 04:00 PM ET
What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 1.50B
How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  244.64
+7.15 (3.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap